H-SRPTEKT-OH

Ref. 3D-PP43678

Informations sur le produit

• Nom: H-SRPTEKT-OH
• Synonymes: NH2-Ser-Arg-Pro-Thr-Glu-Lys-Thr-OH

Description

Peptide H-SRPTEKT-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-SRPTEKT-OH include the following: Characterising the molecular mode of action of connexin therapeutics for the treatment of retinal injury and disease YR Kim - 2016 - researchspace.auckland.ac.nzhttps://researchspace.auckland.ac.nz/handle/2292/30999 Characterizing the mode of action of extracellular Connexin43 channel blocking mimetic peptides in an in vitro ischemia injury model Y Kim, JM Griffin , PWR Harris , SHC Chan - et Biophysica Acta (BBA , 2017 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0304416516304044 Synthesis and biological evaluation of S-lipidated lipopeptides of a connexin 43 channel inhibitory peptide SH Yang, CA Clemett , MA Brimble - RSC Medicinal , 2020 - pubs.rsc.orghttps://pubs.rsc.org/en/content/articlehtml/2020/md/d0md00172d Synthesis and Biological Evaluation of Termini-Modified and Cyclic Variants of the Connexin43 Inhibitor Peptide5 SH Crystal Chan, JM Griffin , CA Clemett - Frontiers in , 2022 - frontiersin.orghttps://www.frontiersin.org/articles/10.3389/fchem.2022.877618/full The lipidated connexin mimetic peptide SRPTEKT-Hdc is a potent inhibitor of Cx43 channels with specificity for the pS368 phospho-isoform ML Cotter, S Boitano, PD Lampe - of Physiology-Cell , 2019 - journals.physiology.orghttps://journals.physiology.org/doi/abs/10.1152/ajpcell.00160.2019 Channels and Transporters in Cell Signaling: The lipidated connexin mimetic peptide SRPTEKT-Hdc is a potent inhibitor of Cx43 channels with specificity for ML Cotter, S Boitano, PD Lampe , JL Solan - American Journal of , 2019 - ncbi.nlm.nih.govhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6850999/ Cell-to-Cell Communication and Signaling Pathways: Lipidated connexin mimetic peptides potently inhibit gap junction-mediated Ca2+-wave propagation ML Cotter, S Boitano, J Vagner - American Journal of , 2018 - ncbi.nlm.nih.govhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6139506/ Lipidated connexin mimetic peptides potently inhibit gap junction-mediated Ca2+-wave propagation ML Cotter, S Boitano, J Vagner - American Journal of , 2018 - journals.physiology.orghttps://journals.physiology.org/doi/abs/10.1152/ajpcell.00156.2017 Development of Potent, Conformation-Specific Inhibitors of Connexin-Mediated Communication ML Cotter - 2018 - search.proquest.comhttps://search.proquest.com/openview/bd62517d1f1e7ec498c46935e566d97b/1?pq-origsite=gscholar&cbl=18750 The lipidated connexin mimetic peptide, SRPTEKT-Hdc, is a potent inhibitor of Cx43 channels 2 with specificity for the pS368 phospho-isoform 3 4 Maura L. Cotter1 JM Burt - journals.physiology.orghttps://journals.physiology.org/doi/prev/20190731-aop/epdf/10.1152/ajpcell.00160.2019 9 10 11 Maura L. Cotter, Scott Boitano, Josef Vagner 3, 4, and Janis M. Burt 12 13 JM Burt - journals.physiology.orghttps://journals.physiology.org/doi/prev/20180406-aop/epdf/10.1152/ajpcell.00156.2017 Prospects for rational development of pharmacological gap junction channel blockers DC Spray , R Rozental, M Srinivas - Current drug targets, 2002 - ingentaconnect.comhttps://www.ingentaconnect.com/content/ben/cdt/2002/00000003/00000006/art00006

• Marque: Biosynth